Amanote Research
Register
Sign In
Circulating miR-107 Could Be a Potential Biomarker for Pancreatic Ductal Adenocarcinoma
HPB
- United Kingdom
doi 10.1016/j.hpb.2018.06.2012
Full Text
Open PDF
Abstract
Available in
full text
Categories
Hepatology
Gastroenterology
Date
September 1, 2018
Authors
N.R. Dash
A. Saraya
S. Rashid
S. Rashid
Publisher
Elsevier BV
Related search
Circulating miR-499 as a Potential Biomarker for Acute Myocardial Infarction
Annals of Translational Medicine
Medicine
Sp1, a New Biomarker That Identifies a Subset of Aggressive Pancreatic Ductal Adenocarcinoma
Cancer Epidemiology Biomarkers and Prevention
Medicine
Epidemiology
Oncology
Circulating miR-95 Is a Potential Biomarker of Chronic Lymphocytic Leukemia
Research in Molecular Medicine (RMM)
Serum miR-21 May Be a Potential Diagnostic Biomarker for Diabetic Nephropathy
Experimental and Clinical Endocrinology and Diabetes
Internal Medicine
Medicine
Diabetes
Metabolism
Endocrinology
Pancreatic Ductal Adenocarcinoma With Cystic Features
HPB
Hepatology
Gastroenterology
Could C-Reactive Protein Be a Potential Biomarker of Complicated Acute Appendicitis?
Hong Kong Journal of Emergency Medicine
Emergency Medicine
Could circRNA Be a New Biomarker for Pre‐eclampsia?
Molecular Reproduction and Development
Genetics
Developmental Biology
Cell Biology
Upregulation of miR-194 Contributes to Tumor Growth and Progression in Pancreatic Ductal Adenocarcinoma
Oncology Reports
Medicine
Cancer Research
Oncology
Macrophage Inhibitory Cytokine 1 (MIC-1/GDF15) as a Novel Diagnostic Serum Biomarker in Pancreatic Ductal Adenocarcinoma
BMC Cancer
Cancer Research
Oncology
Genetics